Bactiguard Holding AB (publ)
The answer first
Does Bactiguard Holding beat the market?
No, Bactiguard Holding has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 45% of Nordic stocks
- Quality55
- Value36
- Trend58
No. 68 of 195 in healthcare
Expectations in the price
Moderate expectations
For the share to return about 9% a year from today's price, the cash Bactiguard Holding keeps must grow about 6% a year for 10 years.
Max for seven days
Follow Bactiguard Holding with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Bactiguard Holding
Your first answer is free, no account needed.
Do you own Bactiguard Holding, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Bactiguard Holding and a few more. Free, no card.
Super Stock+44.6%In short
- Bactiguard Holding has fallen 2.8% over the past year, including dividends.
- Overall, Bactiguard Holding ranks better than 45% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 87.2%. The price is 92.4% below its peak now.
What do analysts think of Bactiguard Holding?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 45% of Nordic stocks.
No. 68 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 116 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.63
- Asset turnoverSales divided by everything the company owns0.41
- Return on equityProfit divided by equity+1.9%
- Cash conversionOperating cash flow divided by profit5.05
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 64 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.7
- P/SPrice divided by sales2.5
- P/EPrice divided by earnings89.2
- P/CFPrice divided by operating cash flow17.7
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 68 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+4.4%
- 6 months−2.2%
- 9 months+5.4%
- 12 months−2.8%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Bactiguard Holding
3 funds we follow own Bactiguard Holding. The share is how much of the fund the stock makes up.
- Sweden3
From the funds' latest known holdings.
About Bactiguard Holding
Bactiguard Holding AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 170 employees.
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for acute, chronic, and infected wounds; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded.


See the full analysis of Bactiguard Holding.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card